IM Cannabis Corp. reported a revenue decline to $7.6 million in Q2 2026 from $12.7 million in Q2 2025, with a net loss of $4.4 million compared to $0.2 million loss a year earlier. The company faced increased operating losses and a shareholders' deficit of $5.5 million as of June 30, 2026, reflecting ongoing financial pressures. IM Cannabis continues to operate medical cannabis platforms in Israel and Germany while exploring growth opportunities, but faces risks including regulatory challenges and market competition. Investors should watch for the company's ability to improve profitability and manage costs moving forward.
Changpeng Zhao, founder of Binance, moved about $965,000 worth of BNB and BinanceLife tokens from a public wallet to his education project, Giggle Academy, on August 16. The wallet had become cluttered with unsolicited meme coins, causing confusion a...
XRP is trading around $1 while futures open interest and trading volumes increase, with traders on Binance and OKX holding heavily leveraged long positions. Despite this bullish positioning, social media sentiment toward XRP has turned the most negat...
Aether Catalyst Solutions, a company focused on reducing costs and improving automotive catalytic converter catalysts, announced the appointment of Benjamin Catalano to its board of directors. Catalano brings over 30 years of experience in corporate ...
In March 2026, JPMorgan Chase launched a program allowing institutional clients to pledge Bitcoin and Ethereum as collateral for U.S. dollar loans via its Kinexys platform, with custodians like Fidelity and Coinbase holding the assets. This marks a m...
Ethereum co-founder Vitalik Buterin highlighted Bitcoin developers' work on Utreexo while outlining Ethereum's proposed hybrid scaling strategy combining UTXO-style state and dynamic state models. Ethereum researcher Toni Wahrstätter proposed native ...
